Subjects: Hyperlipoproteinemia Type II -- drug therapy / Publication Year: 2021 - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Hyperlipoproteinemia Type II -- drug therapy ✖ Publication Year 2021 ✖

1. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

Author(s):: Lin, Grace A., author
Jih, Jane, author
Agboola, Foluso, author
Peason, Steven D., author
Kazi, Dhruv S., author
Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 2, 2021
Subject(s):: Anticholesteremic Agents -- therapeutic use
Atherosclerosis -- prevention & control
ATP Citrate (pro-S)-Lyase -- antagonists & inhibitors
Dicarboxylic Acids -- therapeutic use
Fatty Acids
Hyperlipoproteinemia Type II -- drug therapy
RNA, Small Interfering
Secondary Prevention
Treatment Outcome
Drug Therapy Combination
Ezetimibe -- therapeutic use
United States